Scientists Discover a Potential Role for a common supplement in Fighting Psoriasis

🧬 A Common Dietary Supplement Shows Promise for Treating Psoriasis Through an Unexpected Link to Cholesterol

Recent research has revealed that a dietary supplement derived from vitamin B5, known as pantethine, may help calm immune cells associated with autoimmune inflammation, opening new prospects for treating psoriasis. The study, conducted in China, showed the supplement’s ability to prevent the development of psoriasis in mice and improve symptoms of the disease in a small group of human patients.

The Link Between Cholesterol and the Immune System in Psoriasis

The study highlights the role of dendritic cells, specialized immune cells that help regulate the body’s immune response. Their function is to capture antigens from the body and present them to T cells to activate them, while releasing chemical signals that stimulate inflammation and recruit other immune cells.

However, when these cells become overactive, instead of protecting the body, they can lead to chronic inflammation and autoimmune diseases such as psoriasis. The study linked this to the presence of elevated levels of enzymes called Vanins in dendritic cells from psoriasis patients, enzymes that are involved in certain metabolic processes.

🧪 How Vanins Work and Their Effect on Immune Cell Activity

The enzyme Vanins converts pantethine into vitamin B5, which is necessary for energy production in cells. pantethine is known to be commonly used as a dietary supplement to lower blood cholesterol levels.

But the researchers found that the increased activity of Vanins reduces the amount of pantethine inside dendritic cells, leading to increased cholesterol production within these cells and thus triggering their immune overactivity.

On the other hand, restoring pantethine levels was shown to counteract this biological chain, as the supplement reduces cholesterol accumulation inside the cells and lowers the inflammatory overactivity of immune cells.

📈 Encouraging Results in a Limited Clinical Trial

After successful laboratory experiments and animal trials in mice that showed clear improvement, the team moved on to a small clinical trial involving 24 psoriasis patients. All patients received a topical treatment containing a combination of calcipotriene (a vitamin D derivative that helps regulate skin cell growth) and betamethasone (a corticosteroid to reduce inflammation).

The patients were divided into two groups, and one group additionally received pantethine by mouth. After 12 weeks, the group that took pantethine showed greater improvement in psoriasis symptoms, especially among those who had high blood cholesterol levels before treatment began.

These results suggest that pantethine may be a useful addition to conventional psoriasis treatments, especially for patients whose condition is affected by cholesterol metabolism disorders that contribute to worsening the disease.

🔭 Future Prospects and Limitations

Despite the positive results, the researchers stress that the sample size in the human trial was small, and that larger studies are needed to verify the effectiveness and safety of pantethine as a supportive treatment for psoriasis.

The trial also does not conclusively prove that the biological mechanism seen in laboratory experiments is the same one that operated in patients, which calls for further research to analyze the molecular details and confirm the relationship between the Vanin-pantethine-cholesterol pathway and the regulation of dendritic cell activity.

Nevertheless, this study offers a new framework for understanding how cholesterol metabolism is linked to immune system functions and the amplification of autoimmune inflammation.

📝 Conclusion

The findings of this research represent an important step toward exploring new treatments that focus on the interaction between metabolism and immune cells, as pantethine demonstrates an effective role in modulating the overactivity of dendritic cells associated with psoriasis. With more studies, this common supplement may provide an auxiliary treatment option for patients, especially those with cholesterol imbalances, without relying solely on topical therapies or corticosteroids.

Source: ScienceDaily website

📚 Related articles

🧬 Discovery of Hidden "Death Traces" and the Danger of Viruses Exploiting Them to Spread Infection

2026/09/08

Basic Preventive Measures Against Coronavirus (COVID-19)

2026/09/08

This Common Mistake Could Raise Your Blood Pressure Reading by About 7 Points

2026/10/10